Monoclonal antibody-based therapies for Waldenström's macroglobulinemia

Monoclonal antibodies have established an important role in the treatment armamentarium of hematological malignancies, including Waldenström's macroglobulinemia. Rituximab, an anti-CD20 monoclonal antibody, is established as standard therapy for this unique low grade lymphoma, due to its effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Fotiou, Despina, Theodorakakou, Foteini, Kastritis, Efstathios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098391/
https://www.ncbi.nlm.nih.gov/pubmed/35572915
http://dx.doi.org/10.1016/j.lrr.2022.100324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098391/
https://www.ncbi.nlm.nih.gov/pubmed/35572915
http://dx.doi.org/10.1016/j.lrr.2022.100324

Ejemplares similares